NicOx to shift from nitric oxide-donating approach
This article was originally published in Scrip
Executive Summary
NicOx has told Scrip that its future business does not completely lie in nitric oxide-donating compounds, a mainstay of its business since its inception in 1996. The French firm said that it will start to step away from its traditional focus as it seeks to become a commercial operation.